FDA Drug Application (022369) for LATISSE by ALLERGAN

Back to FDA Applications sponsored by ALLERGAN

Application Number022369
Product Number001
FormSOLUTION/DROPS;TOPICAL
Dosage0.03%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AT Topical products
Reference Drug
Drug NameLATISSE
Active IngredientBIMATOPROST

Active IngredientCount
List of drugs with Active Ingredient BIMATOPROST3


Back to FDA Applications sponsored by ALLERGAN